Applications from the field of Pharma & Biopharma - page 79

Analysis of4-chloro-7tosyl-7H-pyrrolo-[2,3-D]pyrimidine in Tofacitinib Citrate Tablets

Applications

| 2023 | Shimadzu

Consumables, HPLC, LC columns

Instrumentation

Consumables, HPLC, LC columns

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of Phellodendron Bark in Accordance with the Japanese Pharmacopoeia

Applications

| 2023 | Shimadzu

Consumables, HPLC, LC columns

Instrumentation

Consumables, HPLC, LC columns

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

A WORKFLOW FOR PURITY DETERMINATION, INTACT MASS MEASUREMENT AND MS/MS SEQUENCING OF OLIGONUCLEOTIDE IMPURITIES DETECTED IN SYNTHETIC OLIGOS

Posters

| 2023 | Waters (ASMS)

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Waters

Industries

Pharma & Biopharma

Characterization of carbamoylated lysine in a therapeutic recombinant protein using top-down electron fragmentation

Posters

| 2023 | Agilent Technologies (ASMS)

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

“Flash Characterization” of Antibodies via Microdroplet Reactions in an Unmodified Jet Stream Source

Posters

| 2023 | Agilent Technologies (ASMS)

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Rapid Screening of Bispecific Antibodies and Antibody Impurities using In-source Collision Induced Unfolding coupled with IM-MS

Posters

| 2023 | Agilent Technologies (ASMS)

Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

An Improved Method for Quantifying Glyphosine Impurity in Glyphosate API using LC/TQ via Standard Addition

Posters

| 2023 | Agilent Technologies (ASMS)

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Enhanced Extractable Leachable Compound Identification Using New Database Software with Retention Time and Supplemental Collisional Cross Section

Posters

| 2023 | Agilent Technologies (ASMS)

Ion Mobility, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

Ion Mobility, Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Environmental, Food & Agriculture, Pharma & Biopharma

Improved Hydrophilic Interaction Liquid Chromatography for LC/MS Analysis of Released N-Glycans

Posters

| 2023 | Agilent Technologies (ASMS)

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Instrumentation

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System

Posters

| 2023 | Agilent Technologies (ASMS)

LC/MS, LC/MS/MS, LC/QQQ

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma - page 79

Analysis of4-chloro-7tosyl-7H-pyrrolo-[2,3-D]pyrimidine in Tofacitinib Citrate Tablets

Analysis of Phellodendron Bark in Accordance with the Japanese Pharmacopoeia​

A WORKFLOW FOR PURITY DETERMINATION, INTACT MASS MEASUREMENT AND MS/MS SEQUENCING OF OLIGONUCLEOTIDE IMPURITIES DETECTED IN SYNTHETIC OLIGOS

Characterization of carbamoylated lysine in a therapeutic recombinant protein using top-down electron fragmentation

“Flash Characterization” of Antibodies via Microdroplet Reactions in an Unmodified Jet Stream Source

Rapid Screening of Bispecific Antibodies and Antibody Impurities using In-source Collision Induced Unfolding coupled with IM-MS

An Improved Method for Quantifying Glyphosine Impurity in Glyphosate API using LC/TQ via Standard Addition

Enhanced Extractable Leachable Compound Identification Using New Database Software with Retention Time and Supplemental Collisional Cross Section

Improved Hydrophilic Interaction Liquid Chromatography for LC/MS Analysis of Released N-Glycans

Improvement Upon a Multi-Residue Method for Nitrosamine Analysis in Losartan Drug Product Using an Enhanced LC/MS/MS System

Analysis of Phellodendron Bark in Accordance with the Japanese Pharmacopoeia